Exchange Bulletin
Apotex Health Corp. (APTX) To Trade On Toronto Stock Exchange
June 15, 2026
| Issuer: | Apotex Health Corp. (the "Company") |
| Security: | Common shares (the "Shares") |
| Symbol: | APTX |
| Issue price per security: | $24.00 |
| Number of securities issued and outstanding: | 228,499,020 |
| Number of securities reserved for issuance: | 27,141,089 |
| Listing category: | Diversified |
| Trading currency: | CDN$ |
| Transaction: | Initial public offering of Shares (the "Offering") |
| Listing date: | June 15, 2026 (as at 5:01 p.m.) in anticipation of closing of the Offering |
| Anticipated closing date: | June 16, 2026 (prior to the opening) |
| Posted for trading date: | June 16, 2026 (at the opening) subject to confirmation of closing of the Offering |
| End of trading on an "if, as and when issued" basis: | The Shares commenced trading on TSX on an "if, as and when issued" basis on Wednesday, June 10, 2026. Subject to the closing of the Offering occurring as scheduled prior to the opening of business on Tuesday, June 16, 2026, trading on an "if, as and when issued" basis will conclude at the close of business on Monday, June 15, 2026, unless the Offering closing has been delayed. |
| Other markets: | None |
| Temporary market maker: | TD Securities Inc. |
| Investor relations: | Kevin Mannix Vice President, Global Head Capital Markets (212) 262-6596 kmannix@apotexcorp.com -or- Marina Davies Vice President, Head of Investor Relations (416) 562-7984 mdavies@apotex.com |
| Incorporation: | Business Corporations Act (Ontario) |
| Fiscal year end: | March 31 |
| Nature of business: | The Company is a Canadian-based global health company with a broad portfolio of generic, biosimilar and branded pharmaceuticals, as well as branded consumer health and wellness products. |
| Transfer agent and registrar: | Odyssey Trust Company at its principal office in Toronto. |
| Dividends: | The Company anticipates paying quarterly cash dividends of approximately $0.05 per Share, representing an initial annual yield of approximately 0.8% based on the Offering Price. The first dividend that would be payable would be the dividend for the period beginning on the Closing Date to June 30, 2026 and for the first full quarter ending September 30, 2026, is expected to be paid on or about September 30, 2026 to Shareholders of record on September 15, 2026 and is estimated to be $0.06 per Share ($0.01 in respect of the period from and including the Closing Date to June 30, 2026 and $0.05 in respect of the full first quarter ending September 30, 2026). The amount and timing of the payment of any dividends are not guaranteed and are subject to the discretion of the Company's Board. |
| Sponsorship: | Not applicable |
| Offering document: | Supplemented PREP prospectus dated June 10, 2026 (the "Prospectus"), which is available at www.sedarplus.ca. Capitalized terms not otherwise defined herein are as defined in the Prospectus. |
| Initial public offering: | The Offering of Shares will be comprised of: i) a treasury offering by the Company of 35,416,666 Shares; and ii) a secondary offering by the Selling Shareholders of 18,750,004 Shares at an offering price of $24.00 per share (the "Offering Price"), for total gross proceeds of $1,300,000,080, of which $849,999,984 will be received by the Company. In addition, the Selling Shareholders have granted the Underwriters an over-allotment option to purchase up to an additional 8,125,000 Shares at the Offering Price. |
| Additional information: | Please refer to TSX Bulletins 2026-0568 dated June 8, 2026 and 2026-0575 dated June 10, 2026. |
| TSX contact: | Selma Thaver, Managing Director, TSX Listings |